Tenofovir disoproxil Accordpharma 245 mg tabletti, kalvopäällysteinen Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

tenofovir disoproxil accordpharma 245 mg tabletti, kalvopäällysteinen

accord healthcare b.v. - tenofovir disoproxil fumarate - tabletti, kalvopäällysteinen - 245 mg - tenofoviiridisoproksiili

Emtricitabine/Tenofovir Disoproxil Laurus 200 mg / 245 mg tabletti, kalvopäällysteinen Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

emtricitabine/tenofovir disoproxil laurus 200 mg / 245 mg tabletti, kalvopäällysteinen

laurus generics gmbh - tenofovir disoproxil fumarate, emtricitabine - tabletti, kalvopäällysteinen - 200 mg / 245 mg - tenofoviiridisoproksiili ja emtrisitabiini

Emtricitabine/Tenofovir disoproxil Accordpharma 200 mg / 245 mg tabletti, kalvopäällysteinen Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

emtricitabine/tenofovir disoproxil accordpharma 200 mg / 245 mg tabletti, kalvopäällysteinen

accord healthcare b.v. - emtricitabine, tenofovir disoproxil fumarate - tabletti, kalvopäällysteinen - 200 mg / 245 mg - tenofoviiridisoproksiili ja emtrisitabiini

Emtricitabine/Tenofovir Disoproxil Tillomed 200 mg / 245 mg tabletti, kalvopäällysteinen Phần Lan - Tiếng Phần Lan - Fimea (Suomen lääkevirasto)

emtricitabine/tenofovir disoproxil tillomed 200 mg / 245 mg tabletti, kalvopäällysteinen

tillomed pharma gmbh - emtricitabine, tenofovir disoproxil fumarate - tabletti, kalvopäällysteinen - 200 mg / 245 mg - tenofoviiridisoproksiili ja emtrisitabiini

Dimethyl fumarate Mylan Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Eviplera Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

eviplera

gilead sciences international ltd  - emtricitabine, rilpivirine hydrochloride, tenofovir disoproxil fumarate - hiv-infektiot - antiviraalit systeemiseen käyttöön - eviplera on tarkoitettu kohtelu aikuiset kanssa ilman tunnettujen mutaatioiden liittyvät-nucleoside käänteiskopioijaentsyymin estäjiin (nnrti)-, yhdistelmä-tai emtricitabine, immuunikatoviruksen tyypin 1 (hiv-1) ja virus lataa ≤ 100 000 hiv-1 rna kopiota/ml. kuten muillakin antiretroviraalilääkkeillä, genotyyppisen resistenssin testauksen ja / tai historiallisten resistanssitietojen tulisi ohjata eviplera.

Dimethyl fumarate Neuraxpharm Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.